Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time

Sanchez-Rubio, Ferrandez J; Lozano, M C; Iglesias, I; Sanchez-Rubio, Ferrandez L; Rodriguez, Vargas B; Moreno, Diaz R

Abstract

Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time

Author(s): Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R

Issue: Sep/Oct 2012 - Volume 16, Number 5

View All Articles in Issue

Page(s): 431-433

Download in electronic PDF format for $75

Abstract

PhaSeal is a closed-system drug transfer device which has demonstrated to protect against occupational exposure to antineoplastic agents. Our aim was to assess the impact of the incorporation of PhaSeal on the processing time of chemotherapy. The study was a prospective simulation study which compared the processing times with the traditional open-system technique and using the closed-transfer system. Four experienced pharmacy technicians prepared six batches with each method simulating simple chemotherapy admixture operations. We compared the mean times obtained by student's t test and evaluated the “learning effect” between days by ANOVA. The average percentage of time saving with PhaSeal was 31.7% (time per batch [mean±SD] 6.44+0.73 vs. 9.44+0.98 minutes). Mean difference was statistically significant (3.0 min IC95% 2.50-3.50; p>0.0001). No significant learning curve effect was detected. The BD Medical/Carmel Pharma PhaSeal system, in addition to its protective properties, is able to save time in the elaboration process which leads to organization advantages for hospital pharmacy services.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2012 Pg. 431-433	Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Author(s): Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
Mar/Apr 2016 Pg. 148-154	Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) Author(s): Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
Jan/Feb 2022 Pg. 72-79	Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Author(s): Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Nov/Dec 2021 Pg. 515-522	Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding Author(s): Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Sep/Oct 2022 Pg. 358-362	Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Author(s): Lopez C Vidal, Rios GL Quito
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 154-159	Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes Author(s): de Wilde Sofieke, Crul Mirjam, Breukels Oscar
Mar/Apr 2023 Pg. 169-174	Comparison of Three Reconstitution Devices: A Simulated Time and Use Study Author(s): Penoyer Daleen, Giuliano Karen, Middleton Aurea
Mar/Apr 2004 Pg. 126-129	Basics of Compounding for the Treatment of Warts Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 94-99	A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards Author(s): Marks Zach
Jan/Feb 2015 Pg. 30-37	Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance Author(s): Grilli Anthony, Sutton Scott
Nov/Dec 2012 Pg. 446-450	The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Author(s): Pore R David
Nov/Dec 2012 Pg. 456-460	Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Author(s): Lyon Joanna
Nov/Dec 2019 Pg. 454-461	How to Qualify Container Closure Systems for Intended Use, Part 1 Author(s): Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
Jul/Aug 2023 Pg. 340-346	Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Mar/Apr 2018 Pg. 108-121	Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Jul/Aug 2011 Pg. 308-315	Transdermals: The Skin as Part of a Drug Delivery System Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 307-311	Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations Author(s): McElhiney Linda F
Nov/Dec 2006 Pg. 446-448	Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 261-263	Compounding Using Hazardous Drugs Author(s): Lau Kellie